Related Experiment Video
Updated: Jul 4, 2025

08:54
Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
Published on: May 8, 2018
14.3K
Should Stereotactic Ablative Radiotherapy Be Used for Oligometastatic Disease?
Robert A Olson1, David A Palma2
1The University of British Columbia, Vancouver, BC, Canada.
NEJM Evidence
|February 6, 2024
Abstract:
Should SABR Be Used for Oligometastatic Disease?The efficacy of stereotactic ablative radiotherapy in the oligometastatic setting has not been shown in phase 3 randomized controlled trials for breast (or many other) cancers. We review the evidence base and propose a trial to address the question, should stereotactic ablative radiotherapy be used for oligometastatic disease?

